Earnings call transcript: Co2 Capsol AS faces financial hurdles in Q1 2026

Co2 Capsol reported Q1 2026 EBITDA of negative NOK 80 million, with adjusted EBITDA of negative NOK 18 million and no revenue from CapsolGo campaigns apart from a small prepayment. The company cut operating expenses 44% year over year, raised NOK 45 million in equity, and refinanced debt to improve liquidity, but the stock still fell 2.44% to 4.39 after the release. Management said the U.S. CapsolGT project and Stockholm Exergi BECCS remain on track, with more revenue expected from the Dyckerhoff demo in Q2/Q3.

Analysis

This print is less about a clean earnings miss and more about a financing bridge to an inflection point that still may be too far out. The company has successfully de-risked the balance sheet in the near term, but the underlying equity story remains binary: value creation depends on converting a handful of long-cycle engineering relationships into signed FIDs, while the current cash burn requires those milestones to arrive within the next few quarters. The market is likely pricing in execution slippage rather than solvency stress; that distinction matters because liquidity has improved, but equity dilution risk is not gone, just deferred.

The most important second-order effect is competitive. If the U.S. gas-turbine thesis is real, the winner won’t necessarily be the purest carbon-capture vendor — it will be the partner that can bundle EPC, turbine OEM support, and financing into a bankable package for utilities and data-center customers. That favors incumbents with balance-sheet depth and execution credibility, and it raises the bar for any small-cap platform trying to convert pilot interest into scaled deployments. In Europe, the multi-project cement angle is promising, but it also means sales cycles are now closer to strategic procurement than demo economics, so near-term revenue is likely to remain lumpy even if pipeline quality improves.

The setup creates a classic “good story, bad tape” contrast: operational progress is real, but the market probably wants one of two catalysts before re-rating—either a visible step-up in demonstration cash generation over the next 1-2 quarters, or a hard commercial commitment in the U.S. by year-end. Absent that, the stock can stay range-bound or drift lower as investors wait for proof rather than potential. The contrarian view is that the downside may be less about technology risk and more about time-to-cash; if management can keep converting partnerships into paid work, the equity could re-rate quickly because the addressable markets are large and still under-owned.

Key Decisions for Investors

• Avoid chasing the equity here; wait for a confirmed commercial catalyst over the next 1-2 quarters before taking directional exposure. Risk/reward is poor if you buy before proof and absorb another dilution overhang.
• For event-driven exposure, consider a small starter long in CAPSL only against a hard stop on a break below recent support; upside is a re-rating on U.S. project milestones, but downside remains another financing reset if revenue timing slips.
• Pair trade idea: long larger-cap CCUS/industrial decarb enablers with balance-sheet strength, short CAPSL as the execution-risk leg. This isolates sector upside while hedging against small-cap funding and timing risk.
• If available in the local market, use call spreads rather than outright equity for CAPSL over a 3-6 month horizon. The setup is convex, but premium should be capped because the path to monetization is still uncertain.
• Monitor for partner announcements in the U.S. utility/data-center channel; if a credible EPC/OEM-financing stack emerges, that would be the first signal to revisit a long with materially better odds.